| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -150 @ USD 152.97 | USD -22,946 | The ETF sold 150 shares of DVA on 2025-03-31. The shares were previously bought for an average price of USD 156.74. The DaVita HealthCare Partners Inc shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 566 The average price that the ETF previously sold DVA share for is USD 155.473 which is higher than the selling price of USD 152.97 on 2025-03-31. |
| CRL - Creightons Plc | SELL | -168 @ USD 150.52 | USD -25,287 | The ETF sold 168 shares of CRL on 2025-03-31. The shares were previously bought for an average price of USD 173.404. The Creightons Plc shares were sold for -13.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,845 The average price that the ETF previously sold CRL share for is USD 200.064 which is higher than the selling price of USD 150.52 on 2025-03-31. |
| HSIC - Henry Schein Inc | SELL | -402 @ USD 68.49 | USD -27,533 | The ETF sold 402 shares of HSIC on 2025-03-31. The shares were previously bought for an average price of USD 74.049. The Henry Schein Inc shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 2,235 The average price that the ETF previously sold HSIC share for is USD 72.4165 which is higher than the selling price of USD 68.49 on 2025-03-31. |
| TECH - Bio-Techne Corp | SELL | -510 @ USD 58.63 | USD -29,901 | The ETF sold 510 shares of TECH on 2025-03-31. The shares were previously bought for an average price of USD 68.2445. The Bio-Techne Corp shares were sold for -14.1% lower than average price of previous purchases. This resulted in an overall loss of USD 4,903 The average price that the ETF previously sold TECH share for is USD 73.2817 which is higher than the selling price of USD 58.63 on 2025-03-31. |
| MRNA - Moderna Inc | SELL | -1,068 @ USD 28.35 | USD -30,278 | The ETF sold 1068 shares of MRNA on 2025-03-31. The shares were previously bought for an average price of USD 37.5753. The Moderna Inc shares were sold for -24.6% lower than average price of previous purchases. This resulted in an overall loss of USD 9,853 The average price that the ETF previously sold MRNA share for is USD 44.0087 which is higher than the selling price of USD 28.35 on 2025-03-31. |
| INCY - Incyte Corporation | SELL | -522 @ USD 60.55 | USD -31,607 | The ETF sold 522 shares of INCY on 2025-03-31. The shares were previously bought for an average price of USD 70.6241. The Incyte Corporation shares were sold for -14.3% lower than average price of previous purchases. This resulted in an overall loss of USD 5,259 The average price that the ETF previously sold INCY share for is USD 75.5939 which is higher than the selling price of USD 60.55 on 2025-03-31. |
| SOLV - Solventum Corp. | SELL | -432 @ USD 76.04 | USD -32,849 | The ETF sold 432 shares of SOLV on 2025-03-31. The shares were previously bought for an average price of USD 74.5869. The Solventum Corp. shares were sold for 1.9% higher than average price of previous purchases. This sale made a profit of USD 628 The average price that the ETF previously sold SOLV share for is USD 71.4513 so the ETF has sold 432 shares on 2025-03-31 at a higher price than the previous selling average. |
| VTRS - Viatris Inc | SELL | -3,876 @ USD 8.71 | USD -33,760 | The ETF sold 3876 shares of VTRS on 2025-03-31. The shares were previously bought for an average price of USD 10.7568. The Viatris Inc shares were sold for -19.0% lower than average price of previous purchases. This resulted in an overall loss of USD 7,933 The average price that the ETF previously sold VTRS share for is USD 12.741 which is higher than the selling price of USD 8.71 on 2025-03-31. |
| UHS - Universal Health Services Inc | SELL | -186 @ USD 187.9 | USD -34,949 | The ETF sold 186 shares of UHS on 2025-03-31. The shares were previously bought for an average price of USD 190.458. The Universal Health Services Inc shares were sold for -1.3% lower than average price of previous purchases. This resulted in an overall loss of USD 476 The average price that the ETF previously sold UHS share for is USD 197.893 which is higher than the selling price of USD 187.9 on 2025-03-31. |
| ALGN - Align Technology Inc | SELL | -234 @ USD 158.86 | USD -37,173 | The ETF sold 234 shares of ALGN on 2025-03-31. The shares were previously bought for an average price of USD 193.628. The Align Technology Inc shares were sold for -18.0% lower than average price of previous purchases. This resulted in an overall loss of USD 8,136 The average price that the ETF previously sold ALGN share for is USD 225.705 which is higher than the selling price of USD 158.86 on 2025-03-31. |
| RVTY - Revvity Inc. | SELL | -402 @ USD 105.8 | USD -42,532 | The ETF sold 402 shares of RVTY on 2025-03-31. The shares were previously bought for an average price of USD 114.711. The Revvity Inc. shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 3,582 The average price that the ETF previously sold RVTY share for is USD 117.601 which is higher than the selling price of USD 105.8 on 2025-03-31. |
| HOLX - Hologic Inc | SELL | -726 @ USD 61.77 | USD -44,845 | The ETF sold 726 shares of HOLX on 2025-03-31. The shares were previously bought for an average price of USD 68.5407. The Hologic Inc shares were sold for -9.9% lower than average price of previous purchases. This resulted in an overall loss of USD 4,916 The average price that the ETF previously sold HOLX share for is USD 74.0016 which is higher than the selling price of USD 61.77 on 2025-03-31. |
| WST - West Pharmaceutical Services Inc | SELL | -234 @ USD 223.88 | USD -52,388 | The ETF sold 234 shares of WST on 2025-03-31. The shares were previously bought for an average price of USD 270.019. The West Pharmaceutical Services Inc shares were sold for -17.1% lower than average price of previous purchases. This resulted in an overall loss of USD 10,797 The average price that the ETF previously sold WST share for is USD 312.067 which is higher than the selling price of USD 223.88 on 2025-03-31. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -660 @ USD 84.35 | USD -55,671 | The ETF sold 660 shares of COO on 2025-03-31. The shares were previously bought for an average price of USD 90.7453. The The Cooper Companies, Inc. Common Stock shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 4,221 The average price that the ETF previously sold COO share for is USD 100.272 which is higher than the selling price of USD 84.35 on 2025-03-31. |
| BAX - Baxter International Inc | SELL | -1,644 @ USD 34.23 | USD -56,274 | The ETF sold 1644 shares of BAX on 2025-03-31. The shares were previously bought for an average price of USD 33.457. The Baxter International Inc shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,271 The average price that the ETF previously sold BAX share for is USD 33.5922 so the ETF has sold 1644 shares on 2025-03-31 at a higher price than the previous selling average. |
| MOH - MOH | SELL | -180 @ USD 329.39 | USD -59,290 | The ETF sold 180 shares of MOH on 2025-03-31. The shares were previously bought for an average price of USD 305.056. The MOH shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 4,380 The average price that the ETF previously sold MOH share for is USD 311.294 so the ETF has sold 180 shares on 2025-03-31 at a higher price than the previous selling average. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -180 @ USD 329.39 | USD -59,290 | The ETF sold 180 shares of MOH on 2025-03-31. The shares were previously bought for an average price of USD 305.056. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for 8.0% higher than average price of previous purchases. This sale made a profit of USD 4,380 The average price that the ETF previously sold MOH share for is USD 311.294 so the ETF has sold 180 shares on 2025-03-31 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -228 @ USD 262.61 | USD -59,875 | The ETF sold 228 shares of PODD on 2025-03-31. The shares were previously bought for an average price of USD 270.313. The Insulet Corporation shares were sold for -2.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,756 The average price that the ETF previously sold PODD share for is USD 262.463 so the ETF has sold 228 shares on 2025-03-31 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -366 @ USD 169.2 | USD -61,927 | The ETF sold 366 shares of DGX on 2025-03-31. The shares were previously bought for an average price of USD 165.352. The Quest Diagnostics Incorporated shares were sold for 2.3% higher than average price of previous purchases. This sale made a profit of USD 1,408 The average price that the ETF previously sold DGX share for is USD 160.45 so the ETF has sold 366 shares on 2025-03-31 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -270 @ USD 232.74 | USD -62,840 | The ETF sold 270 shares of LH on 2025-03-31. The shares were previously bought for an average price of USD 242.778. The Laboratory Corporation of America Holdings shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 2,710 The average price that the ETF previously sold LH share for is USD 238.869 which is higher than the selling price of USD 232.74 on 2025-03-31. |
| BIIB - Biogen Inc | SELL | -474 @ USD 136.84 | USD -64,862 | The ETF sold 474 shares of BIIB on 2025-03-31. The shares were previously bought for an average price of USD 150.009. The Biogen Inc shares were sold for -8.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,242 The average price that the ETF previously sold BIIB share for is USD 163.553 which is higher than the selling price of USD 136.84 on 2025-03-31. |
| WAT - Waters Corporation | SELL | -192 @ USD 368.57 | USD -70,765 | The ETF sold 192 shares of WAT on 2025-03-31. The shares were previously bought for an average price of USD 375.591. The Waters Corporation shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,348 The average price that the ETF previously sold WAT share for is USD 378.033 which is higher than the selling price of USD 368.57 on 2025-03-31. |
| WAT - MULETFWATIMETFP | SELL | -192 @ USD 368.57 | USD -70,765 | The ETF sold 192 shares of WAT on 2025-03-31. The shares were previously bought for an average price of USD 375.591. The MULETFWATIMETFP shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 1,348 The average price that the ETF previously sold WAT share for is USD 378.033 which is higher than the selling price of USD 368.57 on 2025-03-31. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -642 @ USD 113.18 | USD -72,662 | The ETF sold 642 shares of ZBH on 2025-03-31. The shares were previously bought for an average price of USD 107.442. The Zimmer Biomet Holdings Inc shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 3,684 The average price that the ETF previously sold ZBH share for is USD 109.058 so the ETF has sold 642 shares on 2025-03-31 at a higher price than the previous selling average. |
| STE - STERIS plc | SELL | -324 @ USD 226.65 | USD -73,435 | The ETF sold 324 shares of STE on 2025-03-31. The shares were previously bought for an average price of USD 221.235. The STERIS plc shares were sold for 2.4% higher than average price of previous purchases. This sale made a profit of USD 1,754 The average price that the ETF previously sold STE share for is USD 217.691 so the ETF has sold 324 shares on 2025-03-31 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -66 @ USD 1180.91 | USD -77,940 | The ETF sold 66 shares of MTD on 2025-03-31. The shares were previously bought for an average price of USD 1271.04. The Mettler-Toledo International Inc shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,949 The average price that the ETF previously sold MTD share for is USD 1266.03 which is higher than the selling price of USD 1180.91 on 2025-03-31. |
| MTD - AMUNDI EUR GOV 710 | SELL | -66 @ USD 1180.91 | USD -77,940 | The ETF sold 66 shares of MTD on 2025-03-31. The shares were previously bought for an average price of USD 1271.04. The AMUNDI EUR GOV 710 shares were sold for -7.1% lower than average price of previous purchases. This resulted in an overall loss of USD 5,949 The average price that the ETF previously sold MTD share for is USD 1266.03 which is higher than the selling price of USD 1180.91 on 2025-03-31. |
| DXCM - DexCom Inc | SELL | -1,272 @ USD 68.29 | USD -86,865 | The ETF sold 1272 shares of DXCM on 2025-03-31. The shares were previously bought for an average price of USD 79.7539. The DexCom Inc shares were sold for -14.4% lower than average price of previous purchases. This resulted in an overall loss of USD 14,582 The average price that the ETF previously sold DXCM share for is USD 74.852 which is higher than the selling price of USD 68.29 on 2025-03-31. |
| IQV - IQVIA Holdings Inc | SELL | -546 @ USD 176.3 | USD -96,260 | The ETF sold 546 shares of IQV on 2025-03-31. The shares were previously bought for an average price of USD 199.865. The IQVIA Holdings Inc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 12,866 The average price that the ETF previously sold IQV share for is USD 203.716 which is higher than the selling price of USD 176.3 on 2025-03-31. |
| CNC - Concurrent Technologies Plc | SELL | -1,626 @ USD 60.71 | USD -98,714 | The ETF sold 1626 shares of CNC on 2025-03-31. The shares were previously bought for an average price of USD 60.1448. The Concurrent Technologies Plc shares were sold for 0.9% higher than average price of previous purchases. This sale made a profit of USD 919 The average price that the ETF previously sold CNC share for is USD 59.6677 so the ETF has sold 1626 shares on 2025-03-31 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -390 @ USD 264.6 | USD -103,194 | The ETF sold 390 shares of HUM on 2025-03-31. The shares were previously bought for an average price of USD 273.07. The Hummingbird Resources PLC shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,303 The average price that the ETF previously sold HUM share for is USD 284.238 which is higher than the selling price of USD 264.6 on 2025-03-31. |
| HUM - Humana Inc | SELL | -390 @ USD 264.6 | USD -103,194 | The ETF sold 390 shares of HUM on 2025-03-31. The shares were previously bought for an average price of USD 273.07. The Humana Inc shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,303 The average price that the ETF previously sold HUM share for is USD 284.238 which is higher than the selling price of USD 264.6 on 2025-03-31. |
| RMD - ResMed Inc | SELL | -480 @ USD 223.85 | USD -107,448 | The ETF sold 480 shares of RMD on 2025-03-31. The shares were previously bought for an average price of USD 236.584. The ResMed Inc shares were sold for -5.4% lower than average price of previous purchases. This resulted in an overall loss of USD 6,112 The average price that the ETF previously sold RMD share for is USD 245.848 which is higher than the selling price of USD 223.85 on 2025-03-31. |
| A - Agilent Technologies Inc | SELL | -930 @ USD 116.98 | USD -108,791 | The ETF sold 930 shares of A on 2025-03-31. The shares were previously bought for an average price of USD 134.248. The Agilent Technologies Inc shares were sold for -12.9% lower than average price of previous purchases. This resulted in an overall loss of USD 16,059 The average price that the ETF previously sold A share for is USD 135.829 which is higher than the selling price of USD 116.98 on 2025-03-31. |
| CAH - Cardinal Health Inc | SELL | -792 @ USD 137.77 | USD -109,114 | The ETF sold 792 shares of CAH on 2025-03-31. The shares were previously bought for an average price of USD 126.068. The Cardinal Health Inc shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 9,268 The average price that the ETF previously sold CAH share for is USD 121.207 so the ETF has sold 792 shares on 2025-03-31 at a higher price than the previous selling average. |
| IDXX - IDEXX Laboratories Inc | SELL | -264 @ USD 419.95 | USD -110,867 | The ETF sold 264 shares of IDXX on 2025-03-31. The shares were previously bought for an average price of USD 440.652. The IDEXX Laboratories Inc shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of USD 5,465 The average price that the ETF previously sold IDXX share for is USD 431.776 which is higher than the selling price of USD 419.95 on 2025-03-31. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -1,476 @ USD 80.71 | USD -119,128 | The ETF sold 1476 shares of GEHC on 2025-03-31. The shares were previously bought for an average price of USD 87.2949. The GE HealthCare Technologies Inc. shares were sold for -7.5% lower than average price of previous purchases. This resulted in an overall loss of USD 9,719 The average price that the ETF previously sold GEHC share for is USD 83.8514 which is higher than the selling price of USD 80.71 on 2025-03-31. |
| EW - Edwards Lifesciences Corp | SELL | -1,926 @ USD 72.48 | USD -139,596 | The ETF sold 1926 shares of EW on 2025-03-31. The shares were previously bought for an average price of USD 70.9146. The Edwards Lifesciences Corp shares were sold for 2.2% higher than average price of previous purchases. This sale made a profit of USD 3,015 The average price that the ETF previously sold EW share for is USD 69.2417 so the ETF has sold 1926 shares on 2025-03-31 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -564 @ USD 278.09 | USD -156,843 | The ETF sold 564 shares of COR on 2025-03-31. The shares were previously bought for an average price of USD 247.496. The Cencora Inc. shares were sold for 12.4% higher than average price of previous purchases. This sale made a profit of USD 17,255 The average price that the ETF previously sold COR share for is USD 245.544 so the ETF has sold 564 shares on 2025-03-31 at a higher price than the previous selling average. |
| HCA - HCA Holdings Inc | SELL | -582 @ USD 345.55 | USD -201,110 | The ETF sold 582 shares of HCA on 2025-03-31. The shares were previously bought for an average price of USD 334.95. The HCA Holdings Inc shares were sold for 3.2% higher than average price of previous purchases. This sale made a profit of USD 6,169 The average price that the ETF previously sold HCA share for is USD 335.22 so the ETF has sold 582 shares on 2025-03-31 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -936 @ USD 229.06 | USD -214,400 | The ETF sold 936 shares of BDX on 2025-03-31. The shares were previously bought for an average price of USD 231.809. The Becton Dickinson and Company shares were sold for -1.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,573 The average price that the ETF previously sold BDX share for is USD 226.562 so the ETF has sold 936 shares on 2025-03-31 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -342 @ USD 634.23 | USD -216,907 | The ETF sold 342 shares of REGN on 2025-03-31. The shares were previously bought for an average price of USD 726.298. The Regeneron Pharmaceuticals Inc shares were sold for -12.7% lower than average price of previous purchases. This resulted in an overall loss of USD 31,487 The average price that the ETF previously sold REGN share for is USD 787.092 which is higher than the selling price of USD 634.23 on 2025-03-31. |
| ZTS - Zoetis Inc | SELL | -1,458 @ USD 164.65 | USD -240,060 | The ETF sold 1458 shares of ZTS on 2025-03-31. The shares were previously bought for an average price of USD 169.147. The Zoetis Inc shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 6,557 The average price that the ETF previously sold ZTS share for is USD 176.824 which is higher than the selling price of USD 164.65 on 2025-03-31. |
| MCK - McKesson Corporation | SELL | -408 @ USD 672.99 | USD -274,580 | The ETF sold 408 shares of MCK on 2025-03-31. The shares were previously bought for an average price of USD 603.46. The McKesson Corporation shares were sold for 11.5% higher than average price of previous purchases. This sale made a profit of USD 28,368 The average price that the ETF previously sold MCK share for is USD 604.729 so the ETF has sold 408 shares on 2025-03-31 at a higher price than the previous selling average. |
| CVS - CVS Health Corp | SELL | -4,104 @ USD 67.75 | USD -278,046 | The ETF sold 4104 shares of CVS on 2025-03-31. The shares were previously bought for an average price of USD 61.495. The CVS Health Corp shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of USD 25,671 The average price that the ETF previously sold CVS share for is USD 57.0437 so the ETF has sold 4104 shares on 2025-03-31 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -894 @ USD 329 | USD -294,126 | The ETF sold 894 shares of CI on 2025-03-31. The shares were previously bought for an average price of USD 311.538. The Cigna Corp shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 15,611 The average price that the ETF previously sold CI share for is USD 322.364 so the ETF has sold 894 shares on 2025-03-31 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -750 @ USD 434.96 | USD -326,220 | The ETF sold 750 shares of ELV on 2025-03-31. The shares were previously bought for an average price of USD 406.641. The Elevance Health Inc shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 21,239 The average price that the ETF previously sold ELV share for is USD 408.409 so the ETF has sold 750 shares on 2025-03-31 at a higher price than the previous selling average. |
| ELV - Elevance Health Inc | SELL | -750 @ USD 434.96 | USD -326,220 | The ETF sold 750 shares of ELV on 2025-03-31. The shares were previously bought for an average price of USD 406.641. The Elevance Health Inc shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 21,239 The average price that the ETF previously sold ELV share for is USD 408.409 so the ETF has sold 750 shares on 2025-03-31 at a higher price than the previous selling average. |
| MDT - Medtronic PLC | SELL | -4,170 @ USD 89.86 | USD -374,716 | The ETF sold 4170 shares of MDT on 2025-03-31. The shares were previously bought for an average price of USD 89.2219. The Medtronic PLC shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 2,661 The average price that the ETF previously sold MDT share for is USD 86.7517 so the ETF has sold 4170 shares on 2025-03-31 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -6,606 @ USD 60.99 | USD -402,900 | The ETF sold 6606 shares of BMY on 2025-03-31. The shares were previously bought for an average price of USD 57.9409. The Bloomsbury Publishing Plc shares were sold for 5.3% higher than average price of previous purchases. This sale made a profit of USD 20,142 The average price that the ETF previously sold BMY share for is USD 57.0171 so the ETF has sold 6606 shares on 2025-03-31 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -834 @ USD 484.82 | USD -404,340 | The ETF sold 834 shares of VRTX on 2025-03-31. The shares were previously bought for an average price of USD 476.06. The Vertex Pharmaceuticals Inc shares were sold for 1.8% higher than average price of previous purchases. This sale made a profit of USD 7,306 The average price that the ETF previously sold VRTX share for is USD 480.861 so the ETF has sold 834 shares on 2025-03-31 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -1,122 @ USD 372.25 | USD -417,665 | The ETF sold 1122 shares of SYK on 2025-03-31. The shares were previously bought for an average price of USD 381.827. The Stryker Corporation shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 10,745 The average price that the ETF previously sold SYK share for is USD 380.688 which is higher than the selling price of USD 372.25 on 2025-03-31. |
| DHR - Danaher Corporation | SELL | -2,088 @ USD 205 | USD -428,040 | The ETF sold 2088 shares of DHR on 2025-03-31. The shares were previously bought for an average price of USD 222.321. The Danaher Corporation shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 36,166 The average price that the ETF previously sold DHR share for is USD 238.23 which is higher than the selling price of USD 205 on 2025-03-31. |
| DHR - Danaher Corporation | SELL | -2,088 @ USD 205 | USD -428,040 | The ETF sold 2088 shares of DHR on 2025-03-31. The shares were previously bought for an average price of USD 222.321. The Danaher Corporation shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 36,166 The average price that the ETF previously sold DHR share for is USD 238.23 which is higher than the selling price of USD 205 on 2025-03-31. |
| GILD - Guild Esports Plc | SELL | -4,062 @ USD 112.05 | USD -455,147 | The ETF sold 4062 shares of GILD on 2025-03-31. The shares were previously bought for an average price of USD 101.456. The Guild Esports Plc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 43,033 The average price that the ETF previously sold GILD share for is USD 93.2861 so the ETF has sold 4062 shares on 2025-03-31 at a higher price than the previous selling average. |
| PFE - Pfizer Inc | SELL | -18,456 @ USD 25.34 | USD -467,675 | The ETF sold 18456 shares of PFE on 2025-03-31. The shares were previously bought for an average price of USD 26.257. The Pfizer Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 16,924 The average price that the ETF previously sold PFE share for is USD 26.1916 which is higher than the selling price of USD 25.34 on 2025-03-31. |
| BSX - Boston Scientific Corporation | SELL | -4,794 @ USD 100.88 | USD -483,619 | The ETF sold 4794 shares of BSX on 2025-03-31. The shares were previously bought for an average price of USD 98.1698. The Boston Scientific Corporation shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 12,993 The average price that the ETF previously sold BSX share for is USD 89.4763 so the ETF has sold 4794 shares on 2025-03-31 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -4,794 @ USD 100.88 | USD -483,619 | The ETF sold 4794 shares of BSX on 2025-03-31. The shares were previously bought for an average price of USD 98.1698. The MULSTRXSSXIMETFP shares were sold for 2.8% higher than average price of previous purchases. This sale made a profit of USD 12,993 The average price that the ETF previously sold BSX share for is USD 89.4763 so the ETF has sold 4794 shares on 2025-03-31 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -1,752 @ USD 311.55 | USD -545,836 | The ETF sold 1752 shares of AMGN on 2025-03-31. The shares were previously bought for an average price of USD 303.926. The Amgen Inc shares were sold for 2.5% higher than average price of previous purchases. This sale made a profit of USD 13,357 The average price that the ETF previously sold AMGN share for is USD 297.693 so the ETF has sold 1752 shares on 2025-03-31 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -1,164 @ USD 495.27 | USD -576,494 | The ETF sold 1164 shares of ISRG on 2025-03-31. The shares were previously bought for an average price of USD 552.286. The Intuitive Surgical Inc shares were sold for -10.3% lower than average price of previous purchases. This resulted in an overall loss of USD 66,367 The average price that the ETF previously sold ISRG share for is USD 536.621 which is higher than the selling price of USD 495.27 on 2025-03-31. |
| TMO - Time Out Group plc | SELL | -1,248 @ USD 497.6 | USD -621,005 | The ETF sold 1248 shares of TMO on 2025-03-31. The shares were previously bought for an average price of USD 539.098. The Time Out Group plc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 51,790 The average price that the ETF previously sold TMO share for is USD 534.626 which is higher than the selling price of USD 497.6 on 2025-03-31. |
| MRK - Marks Electrical Group PLC | SELL | -8,244 @ USD 89.76 | USD -739,981 | The ETF sold 8244 shares of MRK on 2025-03-31. The shares were previously bought for an average price of USD 93.921. The Marks Electrical Group PLC shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 34,303 The average price that the ETF previously sold MRK share for is USD 101.307 which is higher than the selling price of USD 89.76 on 2025-03-31. |
| MRK - Merck & Company Inc | SELL | -8,244 @ USD 89.76 | USD -739,981 | The ETF sold 8244 shares of MRK on 2025-03-31. The shares were previously bought for an average price of USD 93.921. The Merck & Company Inc shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 34,303 The average price that the ETF previously sold MRK share for is USD 101.307 which is higher than the selling price of USD 89.76 on 2025-03-31. |
| ABT - Abbott Laboratories | SELL | -5,652 @ USD 132.65 | USD -749,738 | The ETF sold 5652 shares of ABT on 2025-03-31. The shares were previously bought for an average price of USD 125.586. The Abbott Laboratories shares were sold for 5.6% higher than average price of previous purchases. This sale made a profit of USD 39,926 The average price that the ETF previously sold ABT share for is USD 117.111 so the ETF has sold 5652 shares on 2025-03-31 at a higher price than the previous selling average. |
| ABBV - AbbVie Inc | SELL | -5,754 @ USD 209.52 | USD -1,205,578 | The ETF sold 5754 shares of ABBV on 2025-03-31. The shares were previously bought for an average price of USD 191.636. The AbbVie Inc shares were sold for 9.3% higher than average price of previous purchases. This sale made a profit of USD 102,905 The average price that the ETF previously sold ABBV share for is USD 185.942 so the ETF has sold 5754 shares on 2025-03-31 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -7,848 @ USD 165.84 | USD -1,301,512 | The ETF sold 7848 shares of JNJ on 2025-03-31. The shares were previously bought for an average price of USD 158.276. The Johnson & Johnson shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of USD 59,362 The average price that the ETF previously sold JNJ share for is USD 154.492 so the ETF has sold 7848 shares on 2025-03-31 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -3,000 @ USD 523.75 | USD -1,571,250 | The ETF sold 3000 shares of UNH on 2025-03-31. The shares were previously bought for an average price of USD 536.881. The UnitedHealth Group Incorporated shares were sold for -2.4% lower than average price of previous purchases. This resulted in an overall loss of USD 39,393 The average price that the ETF previously sold UNH share for is USD 586.647 which is higher than the selling price of USD 523.75 on 2025-03-31. |
| LLY - Eli Lilly and Company | SELL | -2,568 @ USD 825.91 | USD -2,120,937 | The ETF sold 2568 shares of LLY on 2025-03-31. The shares were previously bought for an average price of USD 842.083. The Eli Lilly and Company shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of USD 41,532 The average price that the ETF previously sold LLY share for is USD 803.997 so the ETF has sold 2568 shares on 2025-03-31 at a higher price than the previous selling average. |